CVS Health Corp.
CVS | NYSE
$88.45
-$1.80 (-1.99%)
Nov 2, 2026, 11:42 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 5.95B | 2.96B | 2.94B | -2.8B | 1.02B | 1.78B | 1.62B | 71M | 1.77B | 1.12B | 2.05B | 2.27B | 1.91B | 2.14B | 2.3B | -3.4B | 3.04B | 2.36B | 1.3B | 1.59B | 2.79B | 2.22B |
Depreciation & Amortization | 2.24B | 1.12B | 1.15B | -2.33B | 1.17B | 1.15B | 1.15B | 1.16B | 1.15B | 1.14B | 1.13B | 1.13B | 1.1B | 1B | 1.05B | 1.05B | 1.08B | 1.05B | 1.12B | 1.13B | 1.14B | 1.13B |
Stock-Based Compensation | 442M | 266M | n/a | -126M | 136M | 126M | 137M | 133M | 133M | 137M | 127M | 154M | 204M | 103M | 106M | 105M | 147M | 89M | 138M | 114M | 145M | 87M |
Other Working Capital | 2.2B | 293M | -2.86B | 1.49B | 14M | 775M | 212M | 2.01B | -2.51B | -537M | -4.78B | 295M | 750M | 5.16B | -4.6B | 9.7B | 1.26B | 638M | 818M | 1.44B | 505M | 259M |
Other Non-Cash Items | n/a | n/a | -221M | 7.34B | -8M | 239M | -993M | 840M | n/a | n/a | 416M | 152M | n/a | n/a | 94M | 2.52B | -225M | n/a | 1.06B | 794M | n/a | n/a |
Deferred Income Tax | -241M | -91M | 542M | 283M | -114M | -169M | 340M | -571M | -124M | -217M | -316M | -250M | -68M | 155M | 175M | -1.97B | -71M | -175M | 217M | -275M | -204M | -166M |
Change in Working Capital | 2.2B | 2M | -1.02B | -1.57B | -309M | 1.43B | -394M | -2.38B | 161M | 2.72B | -6.04B | -732M | 2.75B | 4.04B | -5.68B | 10.81B | 1.47B | 245M | 182M | 2.17B | 1.98B | -379M |
Operating Cash Flow | 10.59B | 4.25B | 3.39B | 796M | 1.9B | 4.56B | 1.86B | -745M | 3.09B | 4.9B | -2.64B | 2.72B | 5.91B | 7.44B | -1.95B | 9.12B | 5.44B | 3.56B | 4.01B | 5.52B | 5.85B | 2.89B |
Capital Expenditures | -1.54B | -849M | -784M | -698M | -607M | -743M | -768M | -670M | -638M | -705M | -911M | -545M | -591M | -984M | -688M | -580M | -408M | -1.05B | -597M | -608M | -486M | -829M |
Cash Acquisitions | -9M | -5M | -7M | 139M | -119M | -20M | -10M | -12M | -48M | -25M | -120M | -18M | -9.38B | -7.09B | 671M | 9M | -2.06B | -7M | -11M | -27M | -24M | -84M |
Purchase of Investments | -8.7B | -4.19B | -3.97B | -3.86B | -3.63B | -3.55B | -2.51B | -5.9B | -3.24B | -3.55B | -2.42B | -2.13B | -2.14B | -2.36B | -1.31B | -1.43B | -1.54B | -3.47B | -2.55B | -1.85B | -2.44B | -3.13B |
Sales Maturities Of Investments | 7.48B | 4.16B | 2.74B | 2.77B | 3.33B | 3.53B | 2.72B | 3.22B | 2.27B | 2.15B | 2.18B | 1.91B | 1.75B | 1.89B | 1.19B | 1.18B | 1.79B | 2.57B | 1.69B | 1.61B | 1.77B | 2.18B |
Other Investing Acitivies | 12M | 7M | 17M | -443M | 4M | 19M | 26M | 15M | 32M | 28M | 25M | 11M | 1M | 31M | 11M | 20M | 85M | -31M | 27M | 23M | 72M | n/a |
Investing Cash Flow | -2.76B | -874M | -2B | -2.09B | -1.02B | -762M | -547M | -3.35B | -1.63B | -2.09B | -1.24B | -771M | -10.36B | -8.51B | -119M | -805M | -2.13B | -1.99B | -1.44B | -847M | -1.11B | -1.87B |
Debt Repayment | -3.29B | -1.52B | -1.27B | -671M | 1.76B | -1.6B | 1.21B | -869M | 2.22B | 2.5B | -232M | -1.95B | 4.52B | 5.59B | -16M | -2.67B | -1.52B | -14M | -2.43B | -1.41B | -2.63B | -2.8B |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1M | 3M | -3.03B | 1M | 3M | 2M | -2.02B | -1.5B | n/a | n/a | -2B | n/a | n/a | n/a | n/a |
Dividend Paid | -1.73B | -847M | -845M | -846M | -866M | -840M | -838M | -837M | -858M | -840M | -779M | -779M | -795M | -779M | -719M | -726M | -740M | -722M | -660M | -659M | -650M | -656M |
Other Financial Acitivies | -216M | -56M | -6M | 18M | -136M | 110M | 63M | 117M | -117M | 139M | 38M | 26M | -103M | -66M | 48M | 174M | -206M | 86M | 260M | 142M | -51M | 268M |
Financial Cash Flow | -5.01B | -2.32B | -2.03B | -1.38B | 806M | -2.33B | 431M | -1.59B | 1.25B | -1.23B | -972M | -2.7B | 3.63B | 2.73B | -2.19B | -3.22B | -2.46B | -2.65B | -2.83B | -1.93B | -3.33B | -3.19B |
Net Cash Flow | 2.83B | 1.06B | -702M | -2.67B | 1.68B | 1.46B | 1.74B | -5.68B | 2.71B | 1.58B | -4.85B | -752M | -828M | 1.65B | -4.26B | 5.1B | 852M | -1.08B | 2.65B | 2.74B | 1.41B | -2.16B |
Free Cash Flow | 9.05B | 3.4B | 2.61B | 98M | 1.29B | 3.81B | 1.09B | -1.42B | 2.45B | 4.2B | -3.55B | 2.17B | 5.32B | 6.45B | -2.64B | 8.54B | 5.04B | 2.51B | 3.41B | 4.91B | 5.36B | 2.06B |
Adj. Free Cash Flow | 8.61B | 3.13B | 2.61B | 224M | 1.15B | 3.69B | 955M | -1.55B | 2.32B | 4.06B | -3.67B | 2.02B | 5.11B | 6.35B | -2.75B | 8.44B | 4.89B | 2.42B | 3.27B | 4.8B | 5.22B | 1.98B |
Maintenance CapEx | -1.54B | -849M | -23.78M | n/a | n/a | -157.24M | -391.12M | -122.23M | -414.31M | -399.49M | n/a | n/a | n/a | -168.72M | -1.68M | n/a | n/a | -318.52M | n/a | n/a | n/a | -614.5M |
Growth CapEx | n/a | n/a | -760.22M | -698M | -607M | -585.76M | -376.88M | -547.77M | -223.69M | -305.51M | -911M | -545M | -591M | -815.28M | -686.32M | -580M | -408M | -732.48M | -597M | -608M | -486M | -214.5M |
Owner Earnings | 9.05B | 3.4B | 3.37B | 796M | 1.9B | 4.4B | 1.47B | -867.23M | 2.67B | 4.5B | -2.64B | 2.72B | 5.91B | 7.27B | -1.95B | 9.12B | 5.44B | 3.24B | 4.01B | 5.52B | 5.85B | 2.28B |
Add to Watchlist
Select watchlists to add or remove CVS